Al-Rashed, F.; Arefanian, H.; Madhoun, A.A.; Bahman, F.; Sindhu, S.; AlSaeed, H.; Jacob, T.; Thomas, R.; Al-Roub, A.; Alzaid, F.;
et al. Neutral Sphingomyelinase 2 Inhibition Limits Hepatic Steatosis and Inflammation. Cells 2024, 13, 463.
https://doi.org/10.3390/cells13050463
AMA Style
Al-Rashed F, Arefanian H, Madhoun AA, Bahman F, Sindhu S, AlSaeed H, Jacob T, Thomas R, Al-Roub A, Alzaid F,
et al. Neutral Sphingomyelinase 2 Inhibition Limits Hepatic Steatosis and Inflammation. Cells. 2024; 13(5):463.
https://doi.org/10.3390/cells13050463
Chicago/Turabian Style
Al-Rashed, Fatema, Hossein Arefanian, Ashraf Al Madhoun, Fatemah Bahman, Sardar Sindhu, Halemah AlSaeed, Texy Jacob, Reeby Thomas, Areej Al-Roub, Fawaz Alzaid,
and et al. 2024. "Neutral Sphingomyelinase 2 Inhibition Limits Hepatic Steatosis and Inflammation" Cells 13, no. 5: 463.
https://doi.org/10.3390/cells13050463
APA Style
Al-Rashed, F., Arefanian, H., Madhoun, A. A., Bahman, F., Sindhu, S., AlSaeed, H., Jacob, T., Thomas, R., Al-Roub, A., Alzaid, F., Malik, M. Z., Nizam, R., Thanaraj, T. A., Al-Mulla, F., Hannun, Y. A., & Ahmad, R.
(2024). Neutral Sphingomyelinase 2 Inhibition Limits Hepatic Steatosis and Inflammation. Cells, 13(5), 463.
https://doi.org/10.3390/cells13050463
